CDC to accelerate testing of new antibiotics using HP’s bioprinters
Date: 2018-08-29   Author: Pankaj Singh  Category: #technology

CDC to accelerate testing of new antibiotics using HP’s bioprinters

The Centers for Disease Control and Prevention (CDC) of the United States is reportedly employing HP’s Biohacker technology in a pilot program to print and test antibiotics, in a bid to restrict the fast spreading of antimicrobial resistant strains. Citing reliable sources, the pilot testing will be initially focusing on widely resistant bacteria and will be conducted at CDC’s regional labs in the first quarter of HP’s fiscal in 2019.       

According to trusted sources, CDC would be using HP’s D300e Digital Dispenser Bioprinter technology, which apparently utilizes the same set-up as a usual inkjet printer, but instead dispenses a mixed combination of drugs in volumes ranging from picolitres to microliters, for conducting research trials.

Reportedly, the bioprinter machines would be available at the regional labs in New York, Tennessee, Minnesota and Wisconsin for printing samples of drugs to be developed, along with conducting antimicrobial susceptibility test methods on the new drugs.

As per medical experts, the reason these bugs spread so rapidly comes down to inappropriate use of antibiotics, eventually enabling the bacteria to develop a strong resistance to the drugs. However, CDC plans on giving hospital nationwide access to the new technology to efficiently counter this issue. 

TechCrunch claims Jean Patel, PhD, Science Team Lead for CDC’s Antibiotic Resistance Coordination and Strategy Unit to have stated that in order to save lives, it is vital to make bioprinter technology accessible to hospital labs across the country. CDC hopes that the pilot trials would offer promising results on its newer drugs that would last longer and provide highly rated lab results to healthcare providers faster.

For the record, 3D bioprinting technology has been experiencing rapid growth over the past few years. The trend is anticipated to continue, mainly owing to research and development activities. in addition, 3D printing technology is supposedly moving towards printing human organs and tissues, besides drug research and developments.

About Author

Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj

Post Recommendents

Lepidolite Market 2024 | Hallgarten and Company, SVS Chemical, Hangzhou J&H Chemical Company Limited, Lithium Australia NL and Univar
Author: Rahul Varpe

Global Lepidolite Market size is anticipated to witness a healthy CAGR during the forecast period. Lepidolite is mica mineral made of potassium, aluminum silicates and lithium. It is an ore of lithium which is usually violet colored, depending on ...

Emulsion Styrene Butadiene Elastomer Market 2024 | Lanxess, Sinopec, Goodyear Tire and Rubber company, CNPC and Zeon
Author: Rahul Varpe

North America, led by the U.S. emulsion styrene butadiene elastomer market size may witness steady growth. Rise in tire manufacturers along with increasing R&D spending  should drive regional growth. Increasing E-SBR demand in adhesives a...

An Inherent Overview Of Stand-Up Pouch Valves Market In Terms Of The Technological Advancements
Author: Rahul Varpe

Global Stand-Up Pouch Valves Market Size, Share and Forecast 2024 released By Global Market Insights, Inc. Report provides Market information about industry Top Key Players, Countries, Type and Application. This Strategy Consulting report also sta...